BioWorld MedTech

Aug. 27, 2018

Senate spending bill for NIH seeks money for drug pricing regulations

The U.S. Senate passed a spending bill that would provide the National Institutes of Health with roughly $39 billion in the coming fiscal year, but the legislation also provides funding for development of drug pricing regulations. Read More

Oxford Biodynamics secures Chinese marketing partner and $12.5M in funding

Researchers use advanced retinal imaging to identify presymptomatic AD patients

Intelligent products are becoming focus of China's future med-tech industry

Head lamp: Rakuten bid with light-activated drug draws $150M in series C

Product briefs

BioWorld MedTech stock report for public med-tech companies

Other news to note

Daily M&A

BioWorld MedTech's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.